查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1578864

黄体酮市场：按类型、给药方法和应用分类 - 2025-2030 年全球预测

Progesterone Market by Type (Natural Progesterone, Synthetic Progesterone), Mode of Delivery (Injectable, Oral, Suspended Form), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年黄体酮市值为13亿美元，预计到2024年将达到14.7亿美元，复合年增长率为13.39%，预计到2030年将达到31.4亿美元。

黄体酮是生殖系统必需的激素，在调节月经週期和维持妊娠方面发挥重要作用，并用于多种治疗。对黄体酮的需求超越了其生理作用，对于荷尔蒙补充疗法、避孕药、月经失调和某些癌症的治疗也至关重要。最终用途范围从製药到生物技术，甚至兽医学，反映了其多功能效用。根据市场洞察，生殖健康意识的提高、妇科疾病发病率的增加以及给药系统的进步是黄体酮市场的关键成长要素。对生物同质激素和天然黄体酮不断增长的需求代表着巨大的市场机会，以及在新治疗领域扩大应用的潜力。公司可以透过投资创新配方和药物输送技术、确保遵守监管标准并专注于有关荷尔蒙疗法的消费者教育来抓住这些机会。然而，市场并非没有挑战。严格的监管要求、与合成产品相关的副作用以及来自替代疗法的竞争是显着的限制因素。新兴市场的价格敏感度和复杂的原料供应链动态也阻碍了成长潜力。为了克服这些挑战，需要加强对更安全、更有效的合成和生物同质製剂的研究。此外，个人化医疗和生物技术的进步为创新提供了肥沃的土壤。儘管市场竞争激烈，但对于能够透过策略联盟、专注于利基市场并利用技术来提高产品功效和安全性来应对这些复杂性的公司来说，机会还是很多的。透过预测监管变化并提供符合消费者偏好的产品，公司可以维持成长并利用黄体酮市场的新趋势。

主要市场统计
基准年[2023] 13亿美元
预测年份 [2024] 14.7亿美元
预测年份 [2030] 31.4亿美元
复合年增长率（%） 13.39%

市场动态：揭示快速发展的黄体酮市场的关键市场洞察

黄体酮市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

波特五力：驾驭黄体素市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解黄体素市场的外部影响

外部宏观环境因素在塑造黄体酮市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解黄体素市场的竞争格局

对黄体酮市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵：黄体素市场供应商绩效评估

FPNV定位矩阵是评估黄体素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製黄体素市场的成功之路

黄体酮市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料以及对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 月经、乳癌和爱滋病的发生率增加
      • 全球女性不孕率上升
      • 妇科治疗多样化导致需求增加
    • 抑制因素
      • 对黄体酮和黄体素副作用的担忧
    • 机会
      • 医疗领域的技术进步
      • 正在进行的研究和开发活动
    • 任务
      • 对荷尔蒙疗法缺乏认识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术的
    • 合法的
    • 环境的

第六章黄体酮市场：依类型

  • 天然黄体酮
  • 合成黄体酮

第七章 黄体素市场：依管理方式分类

  • 注射
  • 口服剂
  • 暂停

第八章黄体酮市场：依应用分类

  • 避孕
  • 子宫功能障碍出血
  • 子宫内膜癌
  • 增生性前驱病变
  • 调整月经週期

第九章美洲黄体酮市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区黄体素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲黄体酮市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alkem Laboratories Ltd.
  • Aquatic Remedies Pvt. Ltd
  • Bionpharma, Inc.
  • Blubell Pharma Group Company
  • Cadila Pharmaceuticals
  • Caesar & Loretz Gmbh
  • Cipla Limited
  • Estrellas Life Sciences Private Limited
  • Fagron Industry
  • Glenmark Pharmaceuticals
  • Intas Pharmaceuticals Ltd.
  • Lupin Limited
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Shandong Octagon Chemicals Limited
  • Shanghai Yijing Industrial Co., Ltd.
  • Sigmak Life Sciences
  • Sofgen Pharmaceuticals Llc
  • Teva Pharmaceuticals Industries Ltd.
  • Virtus Pharmaceuticals Llc
  • Wuhan Honor Bio-Pharm Co., Ltd.
Product Code: MRR-E3708867712D

The Progesterone Market was valued at USD 1.30 billion in 2023, expected to reach USD 1.47 billion in 2024, and is projected to grow at a CAGR of 13.39%, to USD 3.14 billion by 2030.

Progesterone, a vital hormone in the reproductive system, plays a critical role in regulating the menstrual cycle, maintaining pregnancy, and has applications in various medical treatments. The necessity of progesterone extends beyond its physiological roles; it's crucial for hormone replacement therapy, contraceptives, and treatment of menstrual disorders and certain cancers. The end-use scope spans across pharmaceuticals, biotechnology, and even veterinary sectors, reflecting its diverse utility. Market insights indicate that the growing awareness of reproductive health, increasing gynecological disorders, and advancements in drug delivery systems are pivotal growth factors in the progesterone market. The rising demand for bio-identical hormones and natural progesterone represents significant market opportunities, as does the potential for expanding applications in newer therapeutic areas. Companies could capture these opportunities by investing in innovative drug formulations and delivery technologies, ensuring compliance with regulatory standards, and focusing on consumer education regarding hormone therapies. However, the market is not without challenges. Stringent regulatory requirements, side effects associated with synthetic variants, and competition from alternative therapies pose notable limitations. Price sensitivity in emerging markets and complex supply chain dynamics for raw materials also hinder growth potential. To overcome these challenges, there's a need for increased research into safer, more efficient synthetic and bio-identical progesterone formulations. Moreover, advancements in personalized medicine and biotechnology present fertile ground for innovation. The nature of the market is competitive yet ripe with opportunities for businesses that can navigate these complexities through strategic partnerships, focusing on niche markets, and leveraging technology to improve product efficacy and safety. By anticipating regulatory changes and aligning product offerings with consumer preferences, companies can sustain growth and capitalize on emerging trends in the progesterone market.

KEY MARKET STATISTICS
Base Year [2023] USD 1.30 billion
Estimated Year [2024] USD 1.47 billion
Forecast Year [2030] USD 3.14 billion
CAGR (%) 13.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Progesterone Market

The Progesterone Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of amenorrhea, breast cancer, and AIDS
    • Growing female infertility rates all over the globe
    • Increasing demand owing to different gynecological treatment
  • Market Restraints
    • Concern associated with side effects of progesterone and progestin
  • Market Opportunities
    • Technological advancements in the medical field
    • Ongoing research and development activities
  • Market Challenges
    • Lack of awareness about hormone therapy

Porter's Five Forces: A Strategic Tool for Navigating the Progesterone Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Progesterone Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Progesterone Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Progesterone Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Progesterone Market

A detailed market share analysis in the Progesterone Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Progesterone Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Progesterone Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Progesterone Market

A strategic analysis of the Progesterone Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Progesterone Market, highlighting leading vendors and their innovative profiles. These include Alkem Laboratories Ltd., Aquatic Remedies Pvt. Ltd, Bionpharma, Inc., Blubell Pharma Group Company, Cadila Pharmaceuticals, Caesar & Loretz Gmbh, Cipla Limited, Estrellas Life Sciences Private Limited, Fagron Industry, Glenmark Pharmaceuticals, Intas Pharmaceuticals Ltd., Lupin Limited, Shaanxi Hanjiang Pharmaceutical Group Co., Ltd., Shandong Octagon Chemicals Limited, Shanghai Yijing Industrial Co., Ltd., Sigmak Life Sciences, Sofgen Pharmaceuticals Llc, Teva Pharmaceuticals Industries Ltd., Virtus Pharmaceuticals Llc, and Wuhan Honor Bio-Pharm Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Progesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural Progesterone and Synthetic Progesterone.
  • Based on Mode of Delivery, market is studied across Injectable, Oral, and Suspended Form.
  • Based on Application, market is studied across Contraception, Dysfunctional Uterine Bleeding, Endometrial Cancer, Hyperplastic Precursor Lesions, and Regulation of the Menstrual Cycle.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of amenorrhea, breast cancer, and AIDS
      • 5.1.1.2. Growing female infertility rates all over the globe
      • 5.1.1.3. Increasing demand owing to different gynecological treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with side effects of progesterone and progestin
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the medical field
      • 5.1.3.2. Ongoing research and development activities
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about hormone therapy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Progesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Natural Progesterone
  • 6.3. Synthetic Progesterone

7. Progesterone Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Suspended Form

8. Progesterone Market, by Application

  • 8.1. Introduction
  • 8.2. Contraception
  • 8.3. Dysfunctional Uterine Bleeding
  • 8.4. Endometrial Cancer
  • 8.5. Hyperplastic Precursor Lesions
  • 8.6. Regulation of the Menstrual Cycle

9. Americas Progesterone Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Progesterone Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Progesterone Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alkem Laboratories Ltd.
  • 2. Aquatic Remedies Pvt. Ltd
  • 3. Bionpharma, Inc.
  • 4. Blubell Pharma Group Company
  • 5. Cadila Pharmaceuticals
  • 6. Caesar & Loretz Gmbh
  • 7. Cipla Limited
  • 8. Estrellas Life Sciences Private Limited
  • 9. Fagron Industry
  • 10. Glenmark Pharmaceuticals
  • 11. Intas Pharmaceuticals Ltd.
  • 12. Lupin Limited
  • 13. Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • 14. Shandong Octagon Chemicals Limited
  • 15. Shanghai Yijing Industrial Co., Ltd.
  • 16. Sigmak Life Sciences
  • 17. Sofgen Pharmaceuticals Llc
  • 18. Teva Pharmaceuticals Industries Ltd.
  • 19. Virtus Pharmaceuticals Llc
  • 20. Wuhan Honor Bio-Pharm Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. PROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. PROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROGESTERONE MARKET DYNAMICS
  • TABLE 7. GLOBAL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROGESTERONE MARKET SIZE, BY NATURAL PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROGESTERONE MARKET SIZE, BY SYNTHETIC PROGESTERONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROGESTERONE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROGESTERONE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROGESTERONE MARKET SIZE, BY SUSPENDED FORM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROGESTERONE MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROGESTERONE MARKET SIZE, BY DYSFUNCTIONAL UTERINE BLEEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROGESTERONE MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROGESTERONE MARKET SIZE, BY HYPERPLASTIC PRECURSOR LESIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROGESTERONE MARKET SIZE, BY REGULATION OF THE MENSTRUAL CYCLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA PROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. PROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. PROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023